Supplementary Figure S11 from Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration-Resistant Prostate Cancer | Synapse
September 13, 2024
Supplementary Figure S11 from Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration-Resistant Prostate Cancer
Key Points
Key points are not available for this paper at this time.
Abstract
ctDNA TF response is more closely correlated with survival than PSA50 response in discordant cases